Trade Report: The Sanofi’s (SNY) “Buy” Rating Reaffirmed at Leerink Swann

The Sanofi’s (SNY) “Buy” Rating Reaffirmed at Leerink Swann

Sanofi (NYSE:SNY)‘s stock had its “buy” rating reissued by stock analysts at Leerink Swann in a research note issued on Sunday.

Several other research analysts have also recently issued reports on the stock. Zacks Investment Research cut shares of Sanofi from a “hold” rating to a “sell” rating in a report on Wednesday, August 3rd. TheStreet lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Monday, August 22nd. Berenberg Bank raised Sanofi from a “hold” rating to a “buy” rating in a research note on Thursday, September 8th. Piper Jaffray Cos. started coverage on Sanofi in a research note on Friday, September 23rd. They issued a “neutral” rating for the company. Finally, BNP Paribas raised Sanofi from an “underperform” rating to a “neutral” rating in a research note on Tuesday, September 13th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $60.50.

Shares of Sanofi (NYSE:SNY) opened at 38.53 on Friday. The stock has a 50 day moving average of $38.79 and a 200 day moving average of $40.45. Sanofi has a 1-year low of $37.41 and a 1-year high of $51.88. The company has a market cap of $99.18 billion, a price-to-earnings ratio of 21.36 and a beta of 0.98.

10/09/sanofis-sny-buy-rating-reaffirmed-at-leerink-swann-2.html

Several institutional investors have recently bought and sold shares of SNY. Bessemer Group Inc. raised its position in Sanofi by 77.1% in the second quarter. Bessemer Group Inc. now owns 3,445 shares of the company’s stock valued at $144,000 after buying an additional 1,500 shares in the last quarter. Signaturefd LLC raised its position in Sanofi by 16.4% in the second quarter. Signaturefd LLC now owns 3,480 shares of the company’s stock valued at $146,000 after buying an additional 490 shares in the last quarter. JFS Wealth Advisors LLC raised its position in Sanofi by 3.5% in the second quarter. JFS Wealth Advisors LLC now owns 3,961 shares of the company’s stock valued at $166,000 after buying an additional 134 shares in the last quarter. BlackRock Institutional Trust Company N.A. bought a new position in Sanofi during the first quarter valued at about $175,000. Finally, Bradley Foster & Sargent Inc. CT bought a new position in Sanofi during the second quarter valued at about $205,000. 9.42% of the stock is owned by hedge funds and other institutional investors.

About Sanofi

Related posts

Leave a Comment